Taro Pharmaceutical Industries Ltd.
(NYSE : TARO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
ZTSZoetis, Inc. -1.51%158.891.9%$237.24m
TEVATeva Pharmaceutical Industries Ltd. -1.81%11.932.0%$99.43m
MYLMylan NV -0.40%16.363.2%$72.07m
COCPCocrystal Pharma, Inc. -1.92%2.040.0%$12.48m
RDYDr. Reddy's Laboratories Ltd. -0.72%60.742.0%$10.42m
TXMDTherapeuticsMD, Inc. 3.73%1.6722.1%$9.70m
JAGXJaguar Health, Inc. -3.75%0.751.7%$5.24m
ABEOAbeona Therapeutics, Inc. 0.00%2.864.5%$2.05m
TAROTaro Pharmaceutical Industries Ltd. -0.66%62.836.5%$1.87m
KINKindred Biosciences, Inc. 5.01%4.190.3%$1.10m
LFVNLifeVantage Corp. 1.19%13.563.3%$0.67m
CPHIChina Pharma Holdings, Inc. -4.37%0.490.1%$0.38m

Company Profile

Taro Pharmaceutical Industries Ltd. is engaged in the development, manufacturing, and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada, and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.